← FDA DRUG APPROVALS

FDA ANDA · ANDA085866

SODIUM BUTABARBITAL

Sponsor: LANNETT

APPLICATION
ANDA085866
TYPE
ANDA
ORIGINAL APPROVAL
1978-07-20
LATEST ACTION
2019-02-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SODIUM BUTABARBITALDiscontinued
BUTABARBITAL SODIUM 30MG · TABLET · ORAL

Approval history

2019-02-06Labeling · Supplement 7 · standardAP
1978-07-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →